Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Current Debt (2024 - 2025)

Updated

Analysis

Bioxytran (BIXT) Current Debt (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10,000.00
Sep 30, 2025 12,000.00
Dec 31, 2024 10,000.00
Mar 31, 2024 38,000.00
API Access

Bioxytran Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BIXT&period=max&api_key=YOUR_API_KEY